desoxycorticosterone has been researched along with fasudil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, K; Ishikawa, Y; Ishimura, K; Matsuoka, H; Nishikimi, T; Ono, H | 1 |
| Inoue, H; Ishimaru, K; Kagitani, S; Takabayashi, D; Takata, M; Ueno, H | 1 |
2 other study(ies) available for desoxycorticosterone and fasudil
| Article | Year |
|---|---|
Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Drug Administration Schedule; Ectodysplasins; Gene Expression; Hypertension, Malignant; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Cortex; Membrane Proteins; NADP; Nitric Oxide Synthase Type III; Protein Isoforms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho-Associated Kinases; Tumor Necrosis Factors | 2006 |
Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blood Pressure; Cytokines; Desoxycorticosterone; Endomyocardial Fibrosis; Fibrillar Collagens; Gene Expression; Hypertension; Inflammation; Macrophages; Male; Mineralocorticoids; Monocytes; Plasminogen Activator Inhibitor 1; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary | 2007 |